Trim JPM to 50-70% of financials benchmark weight — Underweight based on confirmed technical breakdown, brutal Q3 comp, and unfavorable macro
Underweight rating reflects convergence of three bearish dimensions: (1) confirmed technical breakdown — three lower highs ($365→$363→$362), MACD below zero with expanding histogram, distribution volume on down days, price ~$10 below VWMA, below all four major moving averages; (2) brutal Q3 comp — normalized Q2 closer to $6.85-7.00 (flattered by non-repeating Q1 special-charge benefit), consensus ~$6.00 implies ~14% sequential decline, $6.50 print against $6.85 comp is a miss not a beat; (3) unfavorable macro — 42% Polymarket odds of three Fed hikes creates credit-cycle headwind, higher-for-longer is 2026 NIM tailwind AND 2027 provisioning headwind, CRE office stress/credit card losses/C&I refinancing pressure already visible in $4.39B Q2 special charge. Rating distinguishes from Hold (five consecutive Holds bled alpha -3.4% to +0.4%) and from Sell (franchise floor historically holds, prior Underweights 9/15-9/17 produced only 0.6-1.0% alpha loss). Q3 scenarios: ≥$6.50 + reaffirm NII guide → upgrade to Hold/Overweight; $6.00-6.50 → maintain Underweight; <$6.00 or NII weakens or provisioning accelerates → exit 50-75%, downgrade to Sell.
| Position | Action |
|---|---|
| Standard Underweight allocation | 50-70% of financials benchmark weight |
| If long exposure mandated | Hedge with $300-310 puts expiring post-Q3 earnings |
| Near-money collar structures | Explicitly AVOID — per 9/25 reflection lesson demonstrating collars within ~12% of spot bleed alpha |
| Target re-entry zone after 200 SMA failure | $300-310 only if 200 SMA fails and gets retested from below |
| Do not chase strength | Do not add above $353.25 |
The current pullback is a technical entry point in a fundamentally accelerating franchise stock—JPM's 41% earnings growth, industry-leading 17.79% ROE, and NII tailwinds from higher-for-longer rates make this a 4-to-1 risk/reward opportunity with 18% upside to the $406 target.
| Indicator | Value | Signal |
|---|---|---|
| Close | 336.59 | neutral |
| 10 EMA | 343.86 | bearish |
| 50 SMA | 353.25 | bearish |
| 200 SMA | 319.74 | bullish |
| RSI | 36.00 | bearish |
| MACD | -3.90 | bearish |
| MACD Signal | -2.12 | bearish |
| MACD Histogram | -1.77 | bearish |
| Bollinger Upper Band | 364.94 | neutral |
| Bollinger Middle Band | 350.21 | neutral |
| Bollinger Lower Band | 335.48 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Sustained close below $319.74 (200 SMA) on above-average volume with 2-3 session hold below
Then: Confirm regime change, exit 50-75% of position, downgrade to Sell
EV: +18% · concedes: Short-term technical momentum is bearish (MACD negative, 50 SMA rolled over); AI deposit-displacement narrative has hurt sentiment (>3% loss attributed to Meta Muse story); No confirmed reversal until price reclaims 50 SMA at $353.25
JPM is a great franchise at the wrong price — the technical breakdown (lower-high sequence intact at $362.06-$365.18, MACD below zero and signal with expanding histogram, VWAP rolling over from $358 to $346.82, 50 SMA declining $357→$353.25), Q3'26 earnings bar raised to a record $7.70 EPS that may not hold, macro deterioration (42% Polymarket odds of 3 Fed hikes, 8% EOY26 recession probability up +2pp WoW), AI disruption narrative already costing 3%+ market cap, and a 2.5x P/B valuation at peak-cycle ROE of 17.8% vs. normal 14-15% combine to produce a -9.95% expected value — making this a SELL.
EV: -9.95%
→ vs conservative: High Q2 comp ($7.70 EPS) is a feature not a defect — the bar everyone fears is the bar JPMorgan clears 9 of 10 times; conservative confuses high bar with impossible bar
→ vs conservative: Higher-for-longer Fed rates are bullish for NII, not bearish — the conservative analyst commits a category error applying generic equity macro to a bank; 42% Polymarket odds of 3 hikes means 58% is 2 or fewer, still flat-to-higher rates which expands JPM's net interest margin
→ vs conservative: Trimming to 50-70% benchmark weight at lower Bollinger band near 200 SMA with 20% gap to analyst target is the actual high-risk decision; selling high-quality franchise at reasonable multiple near technical support is malpractice
→ vs neutral: HOLD with 'tactical bearish lean' reflects timidity, not analysis; RSI 36, lower Bollinger tag, and 4-to-1 risk/reward argue for conviction buying, not waiting for confirmation that will cause them to miss the entry
→ vs conservative: Credit cycle concerns already provisioned; $4.39 billion Q2 charge-off was pre-emptive absorption of known risks; the upside catalysts (QIA, Extell, IB wallet) are completely absent from bear thesis
| neutral |
| ATR | 6.66 | neutral |
| VWMA | 346.82 | bearish |
Support: 335.48 · 319.74 | Resistance: 343.86 · 350.21 · 353.25 · 364.94
JPMorgan Chase technical analysis dated 2026-09-28 shows short-term bearish momentum with price at $336.59 decisively below the 10 EMA ($343.86), 50 SMA ($353.25), and Bollinger middle band ($350.21), while the MACD line at -3.90 has crossed below its signal at -2.12 with histogram expanding negative at -1.77. The stock is tagging the lower Bollinger band at $335.48 with RSI at 36 approaching oversold territory, suggesting a potential relief bounce, though heavy volume on recent down days confirms distribution-like behavior. Long-term trend remains intact with price 5.3% above the 200 SMA at $319.74, and the report recommends HOLD with resistance at $353.25 to reclaim before initiating new longs.
Market Cap
$894.72B
P/E (TTM)
14.43x
Forward P/E
13.44x
PEG Ratio
1.59
Price/Book
2.53x
Dividend Yield
1.92%
Beta
0.975
52-Week High
$366.50
52-Week Low
$279.10
50-Day MA
$353.34
200-Day MA
$321.26
Revenue (TTM)
$186.33B
Net Income (TTM)
$63.63B
Profit Margin
34.92%
Operating Margin
50.39%
ROE
17.79%
ROA
1.36%
Book Value/Share
$133.01
EPS (TTM)
$23.33
Forward EPS
$25.05
Q2'26 Revenue
$52.85B
Q2'26 Net Income
$21.16B
Q2'26 Diluted EPS
$7.70
Q2'26 EPS YoY Growth
+47%
Q2'26 Net Income YoY Growth
+41%
Q2'26 Special Charges
$4.39B
Total Assets (Q2'26)
$5,015.07B
Total Equity (Q2'26)
$374.60B
Tangible Book Value (Q2'26)
$289.25B
Net Loans (Q2'26)
$1,516.31B
Total Debt (Q2'26)
$532.95B
Q2'26 Share Repurchases
$8.79B
Q2'26 Dividends Paid
$4.34B
Diluted Shares Outstanding
2.694B
Share Count Reduction YoY
~3.6%
Annualized Capital Returns
~$52B+
Total Capital Return Yield
~5.5%
Strengths
Concerns
JPMorgan Chase demonstrates exceptional fundamental health with Q2'26 revenue of $52.85B (up 18% YoY) and net income of $21.16B (up 41% YoY), alongside industry-leading profitability metrics including a 17.79% ROE and 50.39% operating margin. The bank maintains a fortress balance sheet with $5.0T in assets, $374.6B in equity, and strong capital generation capacity, while returning approximately $13.1B per quarter to shareholders through buybacks and dividends. Trading at a forward P/E of 13.44x with a 1.92% dividend yield and ~5.5% total capital return yield, JPM offers an attractive risk/reward profile for both growth and income-oriented investors despite near-52-week-high valuation concerns.
Macro: "Higher-for-longer" Fed regime with prediction markets pricing 97% probability of no rate cuts in 2026 and 42% probability of 3 hikes (+18.9pp WoW). Bond yields rising with the market repricing from a cutting cycle to a stable-to-hiking regime. US recession odds at 8% by EOY26 (+2.0pp WoW)—low absolute level but rising directionally, consistent with warnings that elevated rates are damaging the economy. UK recession odds at 10% (+5.5pp WoW); Japan at 4%, showing global desync. The macro setup is bearish for duration-sensitive equities and mixed for banks—NIM tailwinds from higher-for-longer vs. recession tail risk. Rising yields are marginally positive for JPM NIM, but the equity market is prioritizing the recessionary tail over the NIM tail, causing bank stocks to sell off with the broader market.